878
Views
28
CrossRef citations to date
0
Altmetric
Original Article

Gastric neuroendocrine tumors: prevalence in Europe, USA, and Japan, and rationale for treatment with a gastrin/CCK2 receptor antagonist

&
Pages 550-559 | Received 23 Dec 2014, Accepted 11 Jan 2015, Published online: 09 Feb 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Daniel H Kwon, Eric K Nakakura, Emily K Bergsland & Sun-Chuan Dai. (2017) Gastric neuroendocrine tumors: management and challenges. Gastrointestinal Cancer: Targets and Therapy 7, pages 31-37.
Read now

Articles from other publishers (27)

Blake Bentley, Fadi Chanaa & Steven Clayton. (2023) Complete Esophageal Obstruction: A Rare Complication of Zollinger-Ellison Syndrome. ACG Case Reports Journal 10:11, pages e01205.
Crossref
Dongwei Fan, Xuanhe Li, Yousheng Yu, Xingliang Wang, Jun Fang & Cheng Huang. (2023) Correlation between clinicopathological characteristics and the clinical prognosis of patients with gastroenteropancreatic neuroendocrine tumors. Molecular and Clinical Oncology 19:5.
Crossref
Xu Wang, Chun-Jing Lu, Hua Li, Jin-Yan Zhang, Jian-Wei Zheng, Na Wu, Wei-Lin Yang, Juan Yu & Wei-Feng Huang. (2023) Clinicopathological characteristics of autoimmune gastritis: A single-center retrospective study. Clinics and Research in Hepatology and Gastroenterology 47:7, pages 102154.
Crossref
Gabriella Gabos, Valentin Nădășan, Iris Nădășan, Mădălina Petruț, Ioana Bernatchi, Mădălin Bălășescu & Carmen Nicolau. (2023) Clinical characteristics and endoscopic findings in autoimmune gastritis – A retrospective study. Acta Marisiensis - Seria Medica 69:1, pages 61-67.
Crossref
Hoon Jai Chun, Seun Ja Park, Yun Jeong Lim & Si Young SongHoon Jai Chun, Seun Ja Park, Yun Jeong Lim & Si Young Song. 2023. Gastrointestinal Cancer. Gastrointestinal Cancer 437 441 .
Soo In Choi. (2022) Diagnosis and Treatment of Gastric Neuroendocrine Tumors. Journal of Digestive Cancer Research 10:1, pages 1-8.
Crossref
Klaire Exarchou, Nathan A. Stephens, Andrew R. Moore, Nathan R. Howes & D. Mark Pritchard. (2022) New Developments in Gastric Neuroendocrine Neoplasms. Current Oncology Reports 24:1, pages 77-88.
Crossref
Anusha Bapatla, Ameena Syed, Abu Fazal Shaik Mohammed, Cortney V Jones & Rana Ismail. (2021) Type I Gastric Neuroendocrine Tumor Presenting as Acute Upper Gastrointestinal Bleed. Cureus.
Crossref
Sung Woo Jung. (2021) Endoscopic Treatment of Gastric and Duodenal Neuroendocrine Tumors: Present and Future. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 21:1, pages 29-34.
Crossref
Thiruvengadam Muniraj & Harry R. Aslanian. 2021. Geriatric Gastroenterology. Geriatric Gastroenterology 1933 1951 .
Gabriel Antonio Roberto, Carolina Magalhães Britto Rodrigues, Renata D’Alpino Peixoto & Riad Naim Younes. (2020) Gastric neuroendocrine tumor: A practical literature review. World Journal of Gastrointestinal Oncology 12:8, pages 850-856.
Crossref
Ping Hu, Jian’an Bai, Min Liu, Jingwen Xue, Tiaotiao Chen, Rui Li, Xiaoling Kuai, Haijian Zhao, Xiaolin Li, Ye Tian, Wei Sun, Yujia Xiong & Qiyun Tang. (2020) Trends of incidence and prognosis of gastric neuroendocrine neoplasms: a study based on SEER and our multicenter research. Gastric Cancer 23:4, pages 591-599.
Crossref
Amanda M. Laird & Steven K. Libutti. (2020) Management of Other Gastric and Duodenal Neuroendocrine Tumors. Surgical Oncology Clinics of North America 29:2, pages 253-266.
Crossref
Shuichi Terao, Shiho Suzuki, Hiroki Yaita, Koichi Kurahara, Johji Shunto, Takahisa Furuta, Yasuhiko Maruyama, Masanori Ito, Tomoari Kamada, Rika Aoki, Kazuhiko Inoue, Noriaki Manabe & Ken Haruma. (2020) Multicenter study of autoimmune gastritis in Japan: Clinical and endoscopic characteristics. Digestive Endoscopy 32:3, pages 364-372.
Crossref
Thiruvengadam Muniraj & Harry R. Aslanian. 2020. Geriatric Gastroenterology. Geriatric Gastroenterology 1 19 .
Linda M. Pak, Tingsong Yang & Jiping Wang. (2018) Further Classification for Node-Positive Gastric Neuroendocrine Neoplasms. Journal of Gastrointestinal Surgery 23:4, pages 720-729.
Crossref
Fang-Xi Tian, Yu-Qing Cai, Lv-Ping Zhuang, Ming-Fang Chen, Zhong-Biao Xiu, Yi Zhang, Hong Liu, Zhi-Hong Liu, Guo-Ping Liu, Chen Zeng, Fei-Ling Lin, Jing Liu, Si-Ting Huang, Liang-Zhi Zhang & Hua-Yang Lin. (2018) Clinicopathological features and prognosis of patients with gastric neuroendocrine tumors: A population-based study. Cancer Medicine 7:11, pages 5359-5369.
Crossref
Qing He, Hua Gao, Meng Gao, Shengmei Qi, Kun Yang, Yingqi Zhang & Junzhi Wang. (2018) Immunogenicity and safety of a novel tetanus toxoid-conjugated anti-gastrin vaccine in BALB/c mice. Vaccine 36:6, pages 847-852.
Crossref
A. N. Verbovskyi, S. S. Pirogov, S. N. Bogdanov, A. V. Ovchinnikov, V. V. Sokolov & V. M. Khomyakov. (2018) Possibilities of endoscopy in the diagnosis and treatment of III type neuroendocrine tumors of the stomach. Endoskopicheskaya khirurgiya 24:2, pages 51.
Crossref
Bryan Oronsky, Patrick C. Ma, Daniel Morgensztern & Corey A. Carter. (2017) Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas. Neoplasia 19:12, pages 991-1002.
Crossref
Malcolm Boyce, Andrew R. Moore, Liv Sagatun, Bryony N. Parsons, Andrea Varro, Fiona Campbell, Reidar Fossmark, Helge L. Waldum & D. Mark Pritchard. (2017) Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis. British Journal of Clinical Pharmacology 83:3, pages 466-475.
Crossref
Jose L. Ulla Rocha, Angel Salgado, Raquel Sardina Ferreiro, Pablo Fernandez Catalina & Elena Gallardo. (2017) Neuroendocrine Gastroenteropancreatic Tumors: Where Are We?. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 27:1, pages 36-41.
Crossref
Malcolm Boyce, Katie A Lloyd & D Mark Pritchard. (2016) Potential clinical indications for a CCK2 receptor antagonist. Current Opinion in Pharmacology 31, pages 68-75.
Crossref
Liv Sagatun, Patricia Mjønes, Constantin S. Jianu, Malcolm Boyce, Hege L. Waldum & Reidar Fossmark. (2016) The gastrin receptor antagonist netazepide (YF476) in patients with type 1 gastric enterochromaffin-like cell neuroendocrine tumours: review of long-term treatment. European Journal of Gastroenterology & Hepatology 28:11, pages 1345-1352.
Crossref
Lauren M. Postlewait, Gillian G. Baptiste, Cecilia G. Ethun, Nina Le, Kenneth Cardona, Maria C. Russell, Field F. Willingham, David A. Kooby, Charles A. Staley & Shishir K. Maithel. (2016) A 15-year experience with gastric neuroendocrine tumors: Does type make a difference?. Journal of Surgical Oncology 114:5, pages 576-580.
Crossref
Tian Ming Xu, Chun Sai'er Wang, Cong Wei Jia, Jia Ming Qian & Jing Nan Li. (2016) Clinicopathological features of primary gastric neuroendocrine neoplasms: A single-center analysis. Journal of Digestive Diseases 17:3, pages 162-168.
Crossref
Yuichi Sato, Satoru Hashimoto, Ken-ichi Mizuno, Manabu Takeuchi & Shuji Terai. (2016) Management of gastric and duodenal neuroendocrine tumors. World Journal of Gastroenterology 22:30, pages 6817.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.